What are the characteristic skull findings on X-ray in patients with multiple myeloma?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Skull Findings on X-ray in Multiple Myeloma

The characteristic skull finding on X-ray in multiple myeloma is the presence of multiple "punched-out" osteolytic lesions, which appear as well-defined, round radiolucent defects without sclerotic borders, often described as having a "raindrop" or "Swiss cheese" appearance. 1

Classic Radiographic Appearance

  • Osteolytic lesions are the hallmark finding, appearing as discrete, round, sharply demarcated areas of bone destruction without surrounding reactive bone formation 1
  • These lesions result from increased osteoclastic activity that is not accompanied by compensatory osteoblastic bone formation 2, 3
  • The skull is a common site for these lesions, though they can be present throughout the skeletal system 4

Imaging Characteristics and Limitations

  • Conventional skeletal survey (including skull X-rays) remains the standard technique for detecting lytic lesions and is used in the CRAB criteria (hypercalcemia, renal insufficiency, anemia, bone lesions) for defining myeloma-requiring treatment 1
  • However, radiographic detection has significant limitations—lytic lesions only become visible on X-ray after more than 50% of trabecular bone has been lost 1
  • Skull lesions may be asymptomatic or can grow externally, and rarely there is intracranial expansion 4

Advanced Imaging Considerations

While conventional X-rays remain standard, newer modalities offer superior detection:

  • Whole-body low-dose CT (WBLD-CT) detects up to 60% more relevant findings compared to conventional skeletal surveys and is now recommended as the novel standard procedure for diagnosis of lytic disease 1, 5
  • FDG-PET/CT has 90% sensitivity for detecting various myeloma lesions including focal lesions greater than 5 mm 1
  • However, skull and rib lesions are not as well detected by WBLD-CT or MRI compared to conventional skeletal surveys, so focused skull X-rays may still be valuable when these areas are of clinical concern 5

Clinical Implications

  • The presence of lytic bone lesions on skeletal survey is part of the diagnostic criteria for symptomatic multiple myeloma requiring treatment 1
  • Skull myeloma involvement can affect cranial nerves, with cranial nerves II, V, VI, VII, and VIII being most commonly affected 4
  • Multiple vertebral and skull involvement with osteolytic changes is typical, though solitary lesions can occur 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Treatment for myeloma bone disease.

Clinical cancer research : an official journal of the American Association for Cancer Research, 2006

Research

Myeloma bone disease and treatment options.

European journal of cancer (Oxford, England : 1990), 2006

Research

[Neurologic sequelae of bone changes in multiple myeloma and its therapy].

Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti, 2002

Guideline

Assessment of New Bone Lesions in Treated Multiple Myeloma

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.